ArticleOncotarget2014

HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy.

Ju-Hee Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.